Literature DB >> 19444439

PET/CT of fibrodysplasia ossificans progressiva.

Robert Kulwin1, Larry A Binkovitz.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is an exceedingly rare genetic disorder of connective tissue characterized by extensive and irreversible heterotopic ossification of soft-tissue masses that develop in response to inflammation or trauma. Successful management relies on preventative measures and avoidance of invasive procedures such as intramuscular injections and biopsies. Early diagnosis can prevent extensive heterotopic ossification and is possible with recognition of the classic clinical findings in the feet in association with rapidly evolving soft-tissue masses of the trunk and extremities. Unfortunately, in 87% of the 269 previously reported cases, the diagnosis was not considered initially. Patients are often subjected to biopsy of the soft-tissue masses. The pathology of the fibrodysplasia ossificans progressiva is often confused with sarcoma. These patients might be imaged with PET as part of a standard oncological work-up. We present the first reported PET/CT images of a patient with FOP in order to alert radiologists to this diagnostic pathway. Awareness of the disorder might prevent further unnecessary interventions that can lead to extensive deformity and suffering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444439     DOI: 10.1007/s00247-009-1281-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  MR imaging of early fibrodysplasia ossificans progressiva.

Authors:  K H Caron; M A DiPietro; A M Aisen; K P Heidelberger; W A Phillips; W Martel
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

2.  Fibrodysplasia ossificans progressiva.

Authors:  S Mahboubi; D L Glaser; E M Shore; F S Kaplan
Journal:  Pediatr Radiol       Date:  2001-05

3.  Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Sharon Kantanie; David M Rocke; Frederick S Kaplan
Journal:  Pediatrics       Date:  2005-10-17       Impact factor: 7.124

4.  Early diagnosis of fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Meiqi Xu; David L Glaser; Felicity Collins; Michael Connor; Joseph Kitterman; David Sillence; Elaine Zackai; Vardit Ravitsky; Michael Zasloff; Arupa Ganguly; Eileen M Shore
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

5.  Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva.

Authors:  T F Lanchoney; R B Cohen; D M Rocke; M A Zasloff; F S Kaplan
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

6.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

7.  Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva.

Authors:  W Luchetti; R B Cohen; G V Hahn; D M Rocke; M Helpin; M Zasloff; F S Kaplan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-01

8.  Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva.

Authors:  Gregory K Deirmengian; Nader M Hebela; Michael O'Connell; David L Glaser; Eileen M Shore; Frederick S Kaplan
Journal:  J Bone Joint Surg Am       Date:  2008-02       Impact factor: 5.284

  8 in total
  1 in total

1.  Whole-body Computed Tomography Versus Dual Energy X‑ray Absorptiometry for Assessing Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva.

Authors:  Sarah E Warner; Frederick S Kaplan; Robert J Pignolo; Stacy E Smith; Edward C Hsiao; Carmen De Cunto; Maja Di Rocco; Kathleen Harnett; Donna Grogan; Harry K Genant
Journal:  Calcif Tissue Int       Date:  2021-07-31       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.